Thalassemia Clinical Trials

Boston : Children's Hospital Boston

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Toronto : Toronto Sick Kids Hospital

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Créteil : Groupe Hospitalier Henri Mondor

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Paris : Hôpital Necker-Enfants Malades

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Athens : Novartis Investigative Site

Safety and Efficacy of Deferasirox in β-thalassaemia Patients With Severe Cardiac Iron Overload

Patra : Novartis Investigative Site

Safety and Efficacy of Deferasirox in β-thalassaemia Patients With Severe Cardiac Iron Overload

Thessaloniki : George Papanicolaou Hospital

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Cagliari : Ospedale Regionale Mecrocitemie

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Genoa : Centro della Microcitemia e delle Anemie Congenite

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Orbassano : Thalassemia Center San Luigi Hospital

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Turin : Acceleron Investigative Site

Study of ACE-536 to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia Intermedia

Hazmiyeh : Novartis Investigative Site

An Open Label, Multi-center, Efficacy and Safety Study of Deferasirox in Iron Overloaded Patients With Non-transfusion Dependent Thalassemia

Bangkok : Novartis Investigative Site

An Open Label, Multi-center, Efficacy and Safety Study of Deferasirox in Iron Overloaded Patients With Non-transfusion Dependent Thalassemia

London : UCL Cancer Institue

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.